Table S2 from TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer

Jonathan M. Cooper,Yi-Hung Ou,Elizabeth A. McMillan,Rachel M. Vaden,Aubhishek Zaman,Brian O. Bodemann,Gurbani Makkar,Bruce A. Posner,Michael A. White

crossref（2023）

引用 0|浏览9

暂无评分

摘要

Table S2 contains the data for the comparisons between TBK1 inhibitors (BX795 and Compound II) and published chemical breadth of efficacy screens in NSCLC lines

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要